Century Therapeutics (IPSC) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Century Therapeutics Revenue Highlights


Latest Revenue (Y)

$2.23M

Latest Revenue (Q)

$771.00K

Century Therapeutics Revenue by Period


Century Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$2.23M-57.01%
2022-12-31$5.20M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Century Therapeutics generated $2.23M in revenue during NA 2023, up -57.01% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Century Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$771.00K-9.82%
2024-03-31$855.00K219.03%
2023-12-31$268.00K81.08%
2023-09-30$148.00K49.49%
2023-06-30$99.00K-94.24%
2023-03-31$1.72M230.13%
2022-12-31$521.00K-76.57%
2022-09-30$2.22M59.31%
2022-06-30$1.40M31.95%
2022-03-31$1.06M100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Century Therapeutics generated $771.00K in revenue during Q2 2024, up -9.82% compared to the previous quarter, and up 44.83% compared to the same period a year ago.

Century Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$249.38M$128.18M
RLAYRelay Therapeutics$25.55M-
STOKStoke Therapeutics$8.78M$4.22M
KZRKezar Life Sciences$7.00M-
GBIOGeneration Bio$5.90M$4.06M
IPSCCentury Therapeutics$2.23M$771.00K
FIXXQ32 Bio$1.16M-
LIFEaTyr Pharma$353.00K$235.00K
KROSKeros Therapeutics$151.00K$83.00K
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
NGMNGM Biopharmaceuticals-$165.00K
NKTXNkarta--
ERASErasca--
PASGPassage Bio--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--

IPSC Revenue FAQ


Century Therapeutics's yearly revenue for 2023 was $2.24M, representing a decrease of -57.01% compared to 2022. The company's yearly revenue for 2022 was $5.2M, representing an increase of 100.00% compared to 2021. IPSC's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Century Therapeutics's quarterly revenue for Q2 2024 was $771K, a -9.82% decrease from the previous quarter (Q1 2024), and a 678.79% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $855K, a 219.03% increase from the previous quarter (Q4 2023), and a -50.29% decrease year-over-year (Q1 2023). IPSC's quarterly revenue for Q4 2023 was $268K, a 81.08% increase from the previous quarter (Q3 2023), and a -48.56% decrease year-over-year (Q4 2022).

Century Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.